Related by context. Frequent words. (Click for all words.) 80 tolerability profile 77 pharmacokinetic profile 76 pharmacokinetics 74 efficacy 73 safety tolerability 73 pharmacokinetic 72 immunogenicity 70 pharmacodynamic 69 monotherapy 69 antiviral activity 67 placebo controlled 66 Phase 1b 65 double blind placebo 64 Phase IIa 64 dosing 64 mg dose 64 bioavailability 64 dosing regimen 63 dose escalation 63 Phase IIb 63 Phase 2a 62 Phase IIb clinical 62 docetaxel 62 Phase III clinical 62 RDEA# 61 primary endpoint 61 gemcitabine 61 Phase 2b 61 TMC# [001] 61 preclinical studies 61 randomized double 61 carboplatin 61 randomized placebo controlled 60 orally administered 60 clinical trial 60 Phase IIb trial 60 ANA# 60 MGCD# [002] 60 Zenvia 60 administered orally 60 RG# [001] 59 secondary endpoints 59 Locteron 59 blind placebo controlled 59 non inferiority 59 clinically meaningful 59 VELCADE 59 picoplatin 59 blind randomized placebo 59 oral formulation 59 Efficacy 58 placebo 58 dexamethasone 58 rituximab 58 sunitinib 58 hematologic malignancies 58 multicenter 58 randomized controlled 58 bortezomib 58 pioglitazone 58 ADX# 57 pivotal Phase III 57 pegylated interferon 57 randomized Phase 57 5 FU 57 clinically relevant 57 perifosine 57 secondary endpoint 57 pivotal Phase 57 rivaroxaban 57 sorafenib 57 investigational drug 57 ENBREL 57 primary endpoints 57 Phase III clinical trials 57 randomized clinical trials 56 bavituximab 56 ribavirin 56 randomized clinical 56 prospective randomized 56 PMX # 56 toxicities 56 protease inhibitor 56 AZD# 56 glycemic control 56 demonstrated statistically significant 56 Phase III trials 56 blind randomized 56 ARRY 56 erlotinib 56 lamivudine 56 bioequivalence 56 FOLOTYN 55 evaluable patients 55 preclinical models 55 oxaliplatin 55 free survival PFS 55 G CSF 55 renal function 55 randomized 55 ERBITUX